NIH and FDA Examine Serious Side Effect That Surfaced in COVID Vaccine Trial
By Arthur Allen and Liz Szabo, Kaiser Health News Monday, September 14, 2020 (Kaiser News) — The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation … Read more